ArticleCancer discovery2011

Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance.

Kazuhiro Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.